Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2020 Oct;83(4):1219-1222.
doi: 10.1016/j.jaad.2020.06.1018. Epub 2020 Jul 3.

New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus

Gilles Battesti  1 , Jihane El Khalifa  2 , Nour Abdelhedi  2 , Valentine Ferre  3 , Fabrice Bouscarat  2 , Catherine Picard-Dahan  2 , Florence Brunet-Possenti  2 , Gilles Collin  3 , Justine Lavaud  2 , Patrick Le Bozec  2 , Marion Rousselot  2 , Amélie Tournier  2 , Coralie Lheure  2 , Anne Couvelard  1 , Salima Hacein-Bey-Abina  4 , Amine M Abina  5 , Charlotte Charpentier  3 , Sabine Mignot  6 , Pascale Nicaise  6 , Diane Descamps  3 , Lydia Deschamps  1 , Vincent Descamps  7
Affiliations
Comparative Study

New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus

Gilles Battesti et al. J Am Acad Dermatol. 2020 Oct.
No abstract available

PubMed Disclaimer

References

    1. de Masson A., Bouaziz J.-D., Sulimovic L., et al. Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France. J Am Acad Dermatol. 2020;83:667–670. - PMC - PubMed
    1. Hadjadj J., Yatim N., Barnabei L., et al. Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients. MedRχiv. 2020 https://www.medrxiv.org/content/10.1101/2020.04.19.20068015v1 - DOI - PMC - PubMed
    1. Wrensch F., Winkler M., Pöhlmann S. IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms. Viruses. 2014;6(9):3683–3698. - PMC - PubMed
    1. de Lang A., Baas T., Smits S.L., Katze M.G., Osterhaus A.D., Haagmans B.L. Unraveling the complexities of the interferon response during SARS-CoV infection. Future Virol. 2009;4(1):71–78. - PMC - PubMed
    1. Fallet B., Narr K., Ertuna Y.I., et al. Interferon-driven deletion of antiviral B cells at the onset of chronic infection. Sci Immunol. 2016;1(4):eaah6817. - PMC - PubMed

MeSH terms

Supplementary concepts